Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca’s CVMD Segment: How Did It Perform in 2Q15?
AstraZeneca’s CVMD Segment: How Did It Perform in 2Q15?
AstraZeneca’s CVMD Segment: How Did It Perform in 2Q15?
Submitted by
admin
on August 26, 2015 - 10:43am
Source:
Yahoo/Market Realist
News Tags:
AstraZeneca
cardiovascular disease
metabolic disorders
Onglyza
Crestor
Brilinta
Headline:
AstraZeneca’s CVMD Segment: How Did It Perform in 2Q15?
Do Not Allow Advertisers to Use My Personal information
